These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3405121)

  • 1. X-ray or gamma-ray leukemogenesis at Hiroshima and Nagasaki.
    Rosen P
    Med Hypotheses; 1988 Jul; 26(3):161-4. PubMed ID: 3405121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X- or gamma-ray leukemogenesis in humans.
    Rosen P
    Med Hypotheses; 1981 Jan; 7(1):111-4. PubMed ID: 7207278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray or gamma-ray leukemogenesis in mouse.
    Rosen P
    Med Hypotheses; 1979 Oct; 5(10):1141-4. PubMed ID: 522701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
    Ishimaru T; Otake M; Ischimaru M
    Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
    [No Abstract]   [Full Text] [Related]  

  • 5. Revised dose estimates at Hiroshima and Nagasaki.
    Loewe WE; Mendelsohn E
    Health Phys; 1981 Oct; 41(4):663-6. PubMed ID: 7309523
    [No Abstract]   [Full Text] [Related]  

  • 6. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W; Walsh L; Chomentowski M
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessment of gamma-ray doses in Hiroshima and Nagasaki.
    Maruyama T; Kumamoto Y; Noda Y
    J Radiat Res; 1991 Mar; 32 Suppl():40-7. PubMed ID: 1762130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermoluminescence dosimetry of gamma rays using ceramic samples from Hiroshima and Nagasaki: a comparison with DS86 estimates.
    Nagatomo T; Ichikawa Y; Hoshi M
    J Radiat Res; 1991 Mar; 32 Suppl():48-57. PubMed ID: 1762131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer at Hiroshima and Nagasaki.
    Rosen P
    Med Hypotheses; 1990 Mar; 31(3):209-10. PubMed ID: 2345535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new assessment of the data from Hiroshima and Nagasaki].
    Kellerer AM
    Strahlenschutz Forsch Prax; 1988; 30():63-91. PubMed ID: 3222810
    [No Abstract]   [Full Text] [Related]  

  • 11. Reassessment of gamma doses from the atomic bombs in Hiroshima and Nagasaki.
    Maruyama T; Kumamoto Y; Noda Y
    Radiat Res; 1988 Jan; 113(1):1-14. PubMed ID: 3340713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
    Sasaki MS; Endo S; Hoshi M; Nomura T
    J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutron-induced 63Ni in copper samples from Hiroshima and Nagasaki: a comprehensive presentation of results obtained at the Munich Maier-Leibnitz Laboratory.
    Rühm W; Carroll KL; Egbert SD; Faestermann T; Knie K; Korschinek G; Martinelli RE; Marchetti AA; McAninch JE; Rugel G; Straume T; Wallner A; Wallner C; Fujita S; Hasai H; Hoshi M; Shizuma K
    Radiat Environ Biophys; 2007 Nov; 46(4):327-38. PubMed ID: 17828415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-energy gamma rays in Hiroshima and Nagasaki: implications for risk and WR.
    Straume T
    Health Phys; 1995 Dec; 69(6):954-6. PubMed ID: 7493812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of absorbed dose in thyroids and gonads of survivors in Hiroshima and Nagasaki.
    Hashizume T; Maruyama T; Nishizawa K; Nishimura A
    Acta Radiol Ther Phys Biol; 1974 Oct; 13(5):411-24. PubMed ID: 4462365
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukemia: lessons from the Japanese experience.
    Finch SC
    Stem Cells; 1997; 15 Suppl 2():135-9. PubMed ID: 9368297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia risk from neutrons.
    Rossi HH; Mays CW
    Health Phys; 1978 Apr; 34(4):353-60. PubMed ID: 669955
    [No Abstract]   [Full Text] [Related]  

  • 19. [The new dose estimates for Hiroshima and Nagasaki and the consequences for those survivors exposed to low doses].
    Kellerer AM
    Strahlenschutz Forsch Prax; 1985; 25():2-22. PubMed ID: 3966249
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry.
    Hoshi M; Matsuura M; Hayakawa N; Ito C; Kamada N
    Health Phys; 1996 May; 70(5):735-40. PubMed ID: 8690587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.